Longitudinal changes in laboratory parameters and QTc during isavuconazole therapy in Japanese patients with hematologic malignancies. (PubMed, PLoS One) - Jul 30, 2026 - "ISCZ showed a favorable safety profile in Japanese patients with hematologic malignancies and may be a safe option during QT-prolonging therapies."
Journal • Retrospective data • Hematological Disorders • Hematological Malignancies • Oncology
|
|
Akio Suzuki; Daichi Watanabe; Hiroshi Nakamura; Koichi Ohata; Masahito Shimizu; Mio Wada; Momoko Ohashi; Nobuhiko Nakamura; Nobuhiro Kanemura; Ryo Kobayashi; Takashi Niwa; Takuro Matsumoto; Yoshikazu Ikoma; Yuto Kaneda; Yuto Yamada
|